logo
  

Nasdaq Q1 Results Top Estimates, Boosts Dividend 10 % - Quick Facts

Nasdaq Inc. (NDAQ) reported Wednesday that its net income for the first quarter grew to $298 million or $1.78 per share from $203 million or $1.22 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $327 million or $1.96 per share, compared to $251 million or $1.50 per share in the year-ago quarter.

On average, 17 analysts polled by Thomson Reuters expected the company to report earnings of $1.73 per share for the quarter. Analysts' estimates typically exclude special items.

Net revenues for the quarter rose 21 percent to $851 million from last year's $701 million. Analysts expected revenues of $814.49 million for the quarter.

Solutions segments revenues increased 22 percent, and Market Services revenues increased 20 percent from last year.

The company's Board of Directors also declared a 10 percent higher regular quarterly dividend of $0.54 per share on the company's outstanding common stock, payable on June 25, 2021 to shareholders of record at the close of business on June 11, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Southwest Airlines' flights across the United States were delayed for hours on Monday evening due to technical issue in a weather information system by a third-party weather data provider. The airline later resumed flight operations after solving the issue, but there were delays. The United Kingdom's Competition and Markets Authority or CMA announced Tuesday that it has launched a market study into mobile ecosystems of technology giants Apple Inc. (AAPL) and Google, Inc. (GOOG) over concerns they have market power which is harming users and other businesses. The CMA is taking... Eli Lilly and Co. (LLY) announced Tuesday that it will conduct a head-to-head study comparing once-monthly injectable Emgality (galcanezumab-gnlm) with Nurtec ODT (rimegepant), an orally disintegrating tablet patients take every other day. This study will help to advance the science of migraine treatment...
Follow RTT